Menicon Co., Ltd. (TYO:7780)
Japan · Delayed Price · Currency is JPY 1,142.00
-11.00 (-0.95%)
Jul 16, 2025, 3:30 PM JST
Menicon Revenue
In the fiscal year ending March 31, 2025, Menicon had annual revenue of 121.49B JPY with 4.56% growth. Menicon had revenue of 29.98B in the quarter ending March 31, 2025, with 4.14% growth.
Revenue
121.49B
Revenue Growth
+4.56%
P/S Ratio
0.71
Revenue / Employee
28.09M
Employees
4,325
Market Cap
85.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 121.49B | 5.30B | 4.56% |
| Mar 31, 2024 | 116.19B | 6.00B | 5.44% |
| Mar 31, 2023 | 110.19B | 10.02B | 10.00% |
| Mar 31, 2022 | 100.17B | 13.96B | 16.20% |
| Mar 31, 2021 | 86.21B | 1.69B | 2.00% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |